Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer With or Without Actionable Genomic Alterations (TROPION-LUNG01)
Public ClinicalTrials.gov record NCT04656652. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Phase 3 Randomized Study of DS-1062a Versus Docetaxel in Previously Treated Advanced or Metastatic Non-Small Cell Lung Cancer (TROPION-LUNG01)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy, safety, and pharmacokinetics of DS-1062a versus docetaxel in participants with previously treated advanced or metastatic non-small cell lung cancer (NSCLC) with or without actionable genomic alterations.
Study identification
- NCT ID
- NCT04656652
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 605 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 21, 2020 (Actual)
- Primary completion
- May 10, 2024 (Actual)
- Completion
- Feb 15, 2027 (Estimated)
- Last update posted
- Aug 26, 2026
2020 – 2027
United States locations
- U.S. sites
- 32
- U.S. states
- 22
- U.S. cities
- 31
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Ironwood Cancer and Research Center | Chandler | Arizona | 85224 | — |
| St. Joseph Heritage Healthcare | Anaheim | California | 92835 | — |
| The Oncology Institute of Hope and Innovation | Glendale | California | 91204 | — |
| University of California San Diego | La Jolla | California | 92093 | — |
| UCLA | Los Angeles | California | 90095 | — |
| PIH Health | Whittier | California | 90602 | — |
| Memorial Healthcare System- Memorial Cancer Institute | Hollywood | Florida | 33021 | — |
| Orlando Health | Orlando | Florida | 32806 | — |
| Florida Cancer Specialists | Tallahassee | Florida | 32308 | — |
| Northwestern University | Chicago | Illinois | 60611 | — |
| University of Chicago | Chicago | Illinois | 60637 | — |
| Ft. Wayne Medical Oncology and Hematology | Fort Wayne | Indiana | 46804 | — |
| Baptist Health Louisville | Louisville | Kentucky | 40207 | — |
| Baton Rouge General | Baton Rouge | Louisiana | 70809 | — |
| American Oncology Partners of Maryland | Bethesda | Maryland | 20817 | — |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | — |
| Karmanos Cancer Institute | Detroit | Michigan | 48201 | — |
| OptumCare Cancer Care | Las Vegas | Nevada | 89106 | — |
| Meridian Hematology and Oncology | Manahawkin | New Jersey | 08050 | — |
| Astera Cancer Care | Somerset | New Jersey | 08873 | — |
| Montefiore Medical Center | The Bronx | New York | 10461 | — |
| Messino Cancer Centers | Asheville | North Carolina | 28806 | — |
| University Hospitals Cleveland Medical Center | Cleveland | Ohio | 44106 | — |
| Roger Williams Medical Center | Providence | Rhode Island | 02908 | — |
| Avera Cancer Institute | Sioux Falls | South Dakota | 57105 | — |
| Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | — |
| The Center for Cancer and Blood Disorders | Fort Worth | Texas | 76104 | — |
| Utah Cancer Specialists | Salt Lake City | Utah | 84106 | — |
| University of Virginia Health System | Charlottesville | Virginia | 22903 | — |
| Virginia Cancer Specialist | Fairfax | Virginia | 22031 | — |
| Kadlec Clinic Hematology and Oncology | Kennewick | Washington | 99336 | — |
| Northwest Medical Specialties | Tacoma | Washington | 98405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 177 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04656652, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 26, 2026 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT04656652 live on ClinicalTrials.gov.